Exchange: OTC·Updated 08:05 AM EDT

SBMJF Dimerix Limited

$0.35
$0.1314
(37.54%)
Pre-Market
Prev Close $0.35
Mkt Cap$210.14M
Vol28,879.00

About SBMJF

Dimerix Ltd. engages in the investment of the research and development of biopharmaceutical drugs. It focuses on the development of Dimerix DMX-200 drug candidate in both renal and respiratory indications and the development of Dimerix DMX-700 pre-clinical asset in Chronic Obstructive Pulmonary Disease. The company was founded on May 13, 1975 and is headquartered in Melbourne, Australia.
50

Neutral Sentiment

How do you feel about SBMJF?

Advertisement|Remove ads.